AA
GEVA

ALPS Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

ALPS Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18,432
Closed -$1.8M – 696
2015
Q1 		$1.8M Buy
+18,432
New +$1.95M 0.01% 156

ALPS Advisors's GEVA Position: Q2 2015 in Review

ALPS Advisors sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 18,432 shares — an estimated $1.8M sold.

ALPS Advisors first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $1.8M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • ALPS Advisors reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • ALPS Advisors sold 18,432 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.8M.
  • ALPS Advisors first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • ALPS Advisors's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.8M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on ALPS Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.